Literature DB >> 29272114

Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework.

Shahad K Alsaiari1, Sachin Patil1, Mram Alyami1, Kholod O Alamoudi1, Fajr A Aleisa2, Jasmeen S Merzaban2, Mo Li3, Niveen M Khashab1.   

Abstract

CRISPR/Cas9 is a combined protein (Cas9) and an engineered single guide RNA (sgRNA) genome editing platform that offers revolutionary solutions to genetic diseases. It has, however, a double delivery problem owning to the large protein size and the highly charged RNA component. In this work, we report the first example of CRISPR/Cas9 encapsulated by nanoscale zeolitic imidazole frameworks (ZIFs) with a loading efficiency of 17% and enhanced endosomal escape promoted by the protonated imidazole moieties. The gene editing potential of CRISPR/Cas9 encapsulated by ZIF-8 (CC-ZIFs) is further verified by knocking down the gene expression of green fluorescent protein by 37% over 4 days. The nanoscale CC-ZIFs are biocompatible and easily scaled-up offering excellent loading capacity and controlled codelivery of intact Cas9 protein and sgRNA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29272114     DOI: 10.1021/jacs.7b11754

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  65 in total

Review 1.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

Review 2.  Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.

Authors:  Liangcan He; Yuan Liu; Joseph Lau; Wenpei Fan; Qunying Li; Chao Zhang; Pintong Huang; Xiaoyuan Chen
Journal:  Nanomedicine (Lond)       Date:  2019-05-14       Impact factor: 5.307

3.  Intracellular Delivery of His-Tagged Genome-Editing Proteins Enabled by Nitrilotriacetic Acid-Containing Lipidoid Nanoparticles.

Authors:  Yamin Li; Alice Chukun Li; Qiaobing Xu
Journal:  Adv Healthc Mater       Date:  2018-11-22       Impact factor: 9.933

4.  Gold Nanocluster-Mediated Efficient Delivery of Cas9 Protein through pH-Induced Assembly-Disassembly for Inactivation of Virus Oncogenes.

Authors:  Enguo Ju; Tingting Li; Suzane Ramos da Silva; Shou-Jiang Gao
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-10       Impact factor: 9.229

Review 5.  Recent developments on zinc(ii) metal-organic framework nanocarriers for physiological pH-responsive drug delivery.

Authors:  Weicong Liu; Ying Pan; Weiwei Xiao; Hongjia Xu; Dong Liu; Fei Ren; Xinsheng Peng; Jianqiang Liu
Journal:  Medchemcomm       Date:  2019-10-17       Impact factor: 3.597

Review 6.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

7.  Engineered Interactions with Mesoporous Silica Facilitate Intracellular Delivery of Proteins and Gene Editing.

Authors:  Bin Liu; Wardah Ejaz; Shuai Gong; Myrat Kurbanov; Mine Canakci; Francesca Anson; S Thayumanavan
Journal:  Nano Lett       Date:  2020-04-24       Impact factor: 11.189

8.  Engineering of Nanoscale Coordination Polymers with Biomolecules for Advanced Applications.

Authors:  Jing Mu; Liangcan He; Peng Huang; Xiaoyuan Chen
Journal:  Coord Chem Rev       Date:  2019-09-04       Impact factor: 22.315

9.  Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing.

Authors:  Tuo Wei; Qiang Cheng; Lukas Farbiak; Daniel G Anderson; Robert Langer; Daniel J Siegwart
Journal:  ACS Nano       Date:  2020-07-22       Impact factor: 15.881

Review 10.  Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Authors:  Brittany E Givens; Youssef W Naguib; Sean M Geary; Eric J Devor; Aliasger K Salem
Journal:  AAPS J       Date:  2018-10-10       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.